data-outlier-finder — independently scanned and version-tracked by SaferSkills.
SaferSkills independently audited data-outlier-finder (Agent Skill) and scored it 100/100 (green). The audit ran 55 deterministic rules across Security, Supply Chain, Maintenance, Transparency, and Community; it found 0 high-severity and 0 lower-severity findings. The full rule-by-rule trace and per-finding evidence are below. Free, methodology-open.
Findings & checks · 0 flagged
Every scanned point with the score it earned and what moved between them.
First recorded scan — no prior version to compare against.
The primary manifest — the file an agent reads to learn what this artifact does.
Identifies unusual values, unexpected patterns, and potential stories hidden in a dataset by systematically checking for statistical outliers and contextual anomalies.
Required:
Optional:
A numbered list of findings, ordered by editorial potential. Each finding includes:
Ends with a short summary: how many outliers were found, how many are likely noise vs. potential stories, and what additional data would help confirm the findings.
Dataset: Annual per-capita healthcare spending (USD, PPP-adjusted) for 30 OECD countries, 2018–2023. Source: OECD Health Statistics. I want to find anything surprising that could anchor a comparative healthcare story for a general-interest magazine.
Finding 1: The United States remains a dramatic outlier at $12,555 per capita (2023) The US spends 2.3× the OECD median ($5,460). This gap has widened, not narrowed, since 2018 (+18% vs. OECD median +12%). The editorial angle isn't the outlier itself — that's well known — but the acceleration. The gap is growing faster than most readers assume. Reporting question: What specific cost categories are driving the widening gap? Is it pharmaceuticals, administrative overhead, or specialist fees?
Finding 2: Turkey's spending jumped 34% between 2021 and 2023 From $1,650 to $2,210 — the fastest growth rate in the dataset by a wide margin. The OECD average grew 8% over the same period. This is not a statistical artefact; the increase is consistent across both years. Reporting question: Is this driven by post-earthquake health infrastructure spending, a policy expansion, or currency/PPP adjustment effects? Check whether the increase appears in nominal local-currency terms or only in PPP-adjusted dollars.
Finding 3: Japan's spending barely moved (+2%) despite an aging population Japan spent $4,691 in 2023, up from $4,587 in 2018. In a country where 29% of the population is over 65, flat healthcare spending is the outlier — it contradicts the standard assumption that aging populations drive cost increases. Reporting question: Is Japan suppressing costs through price controls, care rationing, or efficiency gains? Or is the flat figure masking a shift from public to out-of-pocket spending?
Finding 4: Luxembourg appears as a statistical outlier at $7,890, but it's probably noise Luxembourg's small population (660,000) and high cross-border workforce distort per-capita calculations. Many people receiving care in Luxembourg aren't counted in the population denominator. This is a known measurement issue in OECD data. Reporting question: None — flag this as a data limitation rather than a story.
Summary: 4 outliers identified in 180 data points (30 countries × 6 years). Finding 1 is well-trodden but the acceleration angle is fresh. Finding 2 is the strongest lead for original reporting — under-covered and verifiable. Finding 3 is a strong counterintuitive angle for a feature. Finding 4 is noise. Additional data that would help: spending broken down by cost category (hospitals, pharma, admin) and out-of-pocket vs. public expenditure splits.
~30 seconds. Free. No account. Every finding cites a rule and a line of evidence.